Henry Schein
World's largest provider of healthcare products and services to office-based dental and medical practitioners
Henry Schein – About UsHenry Schein, Inc. (Nasdaq: HSIC) is a Fortune 500 products, services, and technology platforms company serving healthcare customers. Founded in 1932 when Henry Schein opened a pharmacy in Queens, New York with a $500 loan, the company expanded into dental supplies in the 1960s and went public in 1995. It is headquartered in Melville, New York, with operations or affiliates in 34 countries and territories and more than 25,000 employees worldwide.
The company believes it is the world's largest provider of healthcare products and services primarily to office-based dental and medical practitioners and alternate sites of care, serving more than one million customers globally. Its product portfolio spans preventatives, infection-control products, dental implants, pharmaceuticals, vaccines, surgical products, and diagnostic tests, distributed from centers carrying more than 300,000 branded and proprietary products.
Henry Schein operates through two segments: Healthcare Distribution and Technology and Value-Added Services. Its technology arm includes Henry Schein One, a joint venture formed with Internet Brands in 2018, offering practice management software such as Dentrix and Dentrix Ascend, patient communication tools, and e-commerce solutions. Company sales reached $13.2 billion in 2025, reflecting a compound annual growth rate of approximately 11% since its IPO.
The company has been actively expanding through acquisitions, including orthopedic device maker TriMed in April 2024 and Acentus, a Continuous Glucose Monitor supplier, in January 2025. Innovations in healthcare distribution, supply chain, or dental/medical technology are highly relevant to Henry Schein given its scale, global reach, and dual focus on physical product distribution and digital practice management solutions.